W
AKRO

WealthCollab’s Akero Therapeutics AKRO Stock Holding History

WealthCollab’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27
Closed -$1.28K – 1025
2025
Q3 		$1.28K Hold
27
– – ﹤0.01% 895
2025
Q2 		$1.44K Buy
+27
New +$1.23K ﹤0.01% 851

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WealthCollab's AKRO Position: Q4 2025 in Review

WealthCollab sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 27 shares — an estimated $1.28K sold.

WealthCollab first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $1.44K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • WealthCollab reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • WealthCollab sold 27 Akero Therapeutics shares in Q4 2025, an estimated $1.28K.
  • WealthCollab first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • WealthCollab's Akero Therapeutics position peaked at $1.44K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on WealthCollab's 13F filing for Q4 2025, filed 27 Jan 2026.